What is the latest ZYDUSLIFE stock price?
The latest stored price for ZYDUSLIFE is Rs 1,192.00 as of 2026-11-16.
ZYDUS LIFESCIENCES LTD is a large-cap stock in Healthcare. This Gimli page shows the latest available ZYDUSLIFE price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for ZYDUSLIFE is Rs 1,192.00 as of 2026-11-16.
ZYDUSLIFE is above 50DMA, above 200DMA. The latest 50DMA is 1,160.40 and the latest 200DMA is 1,048.77.
ZYDUSLIFE has PE 27.64, ROE +15.44%, and ROCE +17.24% in Gimli's latest available snapshot.
ZYDUSLIFE has returned +6.14% over 1 month, +5.00% over 3 months, and +26.21% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 7,754.40 cr | 2,053.20 cr | 925.50 cr | 9.28 |
| 2026-06-30 | 7,802.00 cr | 2,017.30 cr | 1,010.80 cr | 9.35 |
| 2026-03-31 | 7,434.40 cr | 2,291.10 cr | 1,341.00 cr | 12.65 |
| 2025-12-31 | 6,780.40 cr | 1,842.90 cr | 1,042.10 cr | 10.36 |
| 2025-09-30 | 6,232.00 cr | 2,125.00 cr | 1,233.00 cr | 12.53 |
| 2025-06-30 | 6,467.00 cr | 2,243.40 cr | 1,466.80 cr | 14.58 |
| 2025-03-31 | 6,290.20 cr | 1,986.50 cr | 1,170.90 cr | 11.64 |
| 2024-12-31 | 5,123.50 cr | 1,445.10 cr | 1,023.50 cr | 10.17 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 26,719.70 cr | 8,468.00 cr | 5,040.00 cr | 50.09 |
| 2025-03-31 | 22,573.80 cr | 7,108.40 cr | 4,525.50 cr | 44.97 |
| 2024-03-31 | 19,021.50 cr | 5,617.00 cr | 3,859.50 cr | 38.14 |
| 2023-03-31 | 16,877.80 cr | 3,437.90 cr | 1,960.30 cr | 19.30 |
| 2022-03-31 | 8,160.60 cr | 3,688.60 cr | 857.90 cr | nan |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 52,406.60 cr | 855.20 cr | 12,496.00 cr | 29,582.20 cr |
| 2025-03-31 | 37,201.70 cr | 826.80 cr | 3,213.20 cr | 26,358.40 cr |
| 2024-03-31 | 29,280.80 cr | 413.00 cr | 804.20 cr | 22,101.60 cr |
| 2023-03-31 | 25,756.40 cr | 487.80 cr | 1,194.90 cr | 19,688.30 cr |
| 2022-03-31 | 27,795.40 cr | 657.80 cr | 4,220.90 cr | 19,053.80 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 2,116.60 cr | -554.90 cr | n/a |
| 2025-03-31 | 6,781.10 cr | 5,087.40 cr | n/a |
| 2024-03-31 | 3,196.30 cr | 2,289.70 cr | n/a |
| 2023-03-31 | 2,688.80 cr | 1,657.90 cr | n/a |
| 2022-03-31 | 2,104.50 cr | 901.90 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +75.01% | +7.05% | +11.28% | +6.88% | +6.66% | +0.00% |
| 2026-06-30 | +75.01% | +6.88% | +11.27% | +5.12% | +6.83% | +0.00% |
| 2026-06-18 | +75.01% | +6.89% | +11.19% | +4.92% | +6.90% | +0.00% |
| 2026-03-31 | +75.00% | +6.95% | +11.20% | +4.88% | +6.86% | +0.00% |
| 2025-12-31 | +75.00% | +7.06% | +11.09% | +4.71% | +6.85% | +0.00% |
| 2025-09-30 | +74.99% | +7.34% | +10.86% | +4.70% | +6.80% | +0.00% |
| 2025-06-30 | +74.99% | +7.13% | +11.13% | +5.56% | +6.74% | +0.00% |
| 2025-03-31 | +74.99% | +7.32% | +11.01% | +6.36% | +6.68% | +0.00% |
| 2024-12-31 | +74.98% | +7.53% | +10.65% | +6.32% | +6.84% | +0.00% |
| 2024-09-30 | +74.98% | +7.52% | +10.65% | +6.57% | +6.85% | +0.00% |
| 2024-06-30 | +74.98% | +5.59% | +12.64% | +7.24% | +6.80% | +0.00% |
| 2024-03-31 | +74.98% | +5.72% | +12.63% | +6.71% | +6.66% | +0.00% |
| 2023-12-31 | +74.98% | +5.00% | +13.03% | +6.99% | +6.99% | +0.00% |
| 2023-09-30 | +74.98% | +4.86% | +13.09% | +5.94% | +7.07% | +0.00% |
| 2023-06-30 | +74.98% | +4.04% | +13.52% | +5.80% | +7.47% | +0.00% |
| 2023-03-31 | +74.98% | +3.42% | +13.60% | +5.59% | +8.00% | +0.00% |
| 2022-12-31 | +74.98% | +2.52% | +13.69% | +5.56% | +8.81% | n/a |
| 2022-09-30 | +74.98% | +2.61% | +12.94% | +5.36% | +9.48% | n/a |
| 2022-06-30 | +74.88% | +0.08% | +14.80% | n/a | n/a | +0.00% |
| 2022-03-31 | +74.88% | +0.08% | +15.36% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
| MANKIND | MANKIND PHARMA LIMITED | 108,433.48 cr | 47.905015 | +14.41% | +15.86% |
Data snapshot: 2026-11-16. Not investment advice.